Erratum: We need more research and better designs for insulin infusion sets (Journal of Diabetes Science and Technology (2014) 8, 2 (199-202) DOI: 10.1177/1932296814523882);We need more research and better designs for insulin infusion sets

Journal of Diabetes Science and Technology

Volumn 8, Issue 2, 2014, Pages 199-202

  Heinemann, Lutz ^a   Walsh, John ^b   Roberts, Ruth ^c  

^a Science and Co   (Germany)

^b Advanced Metabolic Care and Research   (United States)

^c Diabetes Services Inc   (United States)

Author keywords

CSII; Infusion set; Insulin pumps; Insulin therapy; Pump occlusions; Unexplained hyperglycemia

Indexed keywords

GLUCOSE; INSULIN; POLITEF; STEEL;

BIOSENSOR; BLOOD GLUCOSE MONITORING; CONTINUOUS GLUCOSE MONITORING; DENMARK; EDITORIAL; EQUIPMENT FAILURE; ERYTHEMA; EUROPE; GERMANY; GLUCOSE BLOOD LEVEL; HEALTH CARE DISPARITY; HUMAN; HYPERGLYCEMIA; INFUSION SYSTEM; INSULIN INFUSION; INSULIN INFUSION SET; INSULIN PUMP; METABOLIC REGULATION; PAIN; PRESSURE SENSOR; SKIN IRRITATION; UNITED STATES;

EID: 84900823231     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/1932296814534798     Document Type: Erratum

References (9)

1. Heinemann L, Krinelke L. Insulin infusion set: the Achilles heel of continuous subcutaneous insulin infusion. J Diabetes Sci Technol. 2012;6:954-964.
2. Renard E, Guerci B, Leguerrier AM, Boizel R. Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study. Diabetes Technol Ther. 2010;12:769-773.
3. Patel PJ, Benasi K, Ferrari G, et al. Randomized trial of infusion set function: steel versus teflon. Diabetes Technol Ther. 2014;16:15-19.
4. Keith S, McVey E, Pettis RJ. High sensitivity occlusion detection using fluid pressure monitoring during basal insulin infusion. Diabetes. 2013;62(suppl 1):A249-A250.
5. Walsh J, Roberts R, Bailey T. Guidelines for insulin dosing in continuous subcutaneous insulin infusion using new formulas from a retrospective study of individuals with optimal glucose levels. J Diabetes Sci Technol. 2010;4:1174-1181.
6. Reichert D, Weber D, Kaltheuner M, Scheper N, Faber-Heinemann G, Heinemann L. Realität der Insulinpumpentherapie in Diabetesschwerpunktpraxen: Daten von 1142 Patienten aus 40 diabetologischen Schwerpunktpraxen. Diabetes, Stoffwechsel und Herz. 2013;22:367-375.
7. Colquitt JL, Green C, Sidhu MK, Hartwell D, Waugh N. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess. 2004;8:iii, 1-iii, 171.
8. Liebner T, Holl R, Heidtmann B, et al. Insulinpumpenkatheter Komplikationen im Kindes- und Jugendalter. Diabetologie und Stoffwechsel. 2011;6:S52.
9. Schmid V, Hohberg C, Borchert M, Forst T, Pfutzner A. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3. J Diabetes Sci Technol. 2010;4:976-982.